CD274 and neoplasm: Anti-PD-L1 was linked to exosome with a responsive peptide that will be cleaved in the presence of MMP-2, and the cleaved anti-PD-L1 could bind to the PD-L1 receptor on tumor cells to block the immune checkpoint.